| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Common stock | 8,508 | $184,113 | $21.64 | 17 Oct 2022 | Direct |
| AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Performance share units | 1,883 | $40,748 | $21.64 | 18 Feb 2022 | Direct |
| AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock options (right to buy) | 41,000 | 01 Mar 2022 | Direct | ||
| AGIOS PHARMACEUTICALS, INC. | Chief Commercial Officer | Restricted stock units | 0 | $24.79 | 15 Oct 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | 15 Oct 2022 | 3 | -$40,808 | 4 | Chief Commercial Officer | 18 Oct 2022, 16:17 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 01 Mar 2022 | 2 | $0 | 4 | Chief Commercial Officer | 03 Mar 2022, 15:09 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 18 Feb 2022 | 5 | -$21,577 | 4 | Chief Commercial Officer | 23 Feb 2022, 15:11 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 14 Feb 2022 | 3 | -$17,995 | 4 | Chief Commercial Officer | 16 Feb 2022, 16:00 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 10 Feb 2022 | 3 | -$22,783 | 4 | Chief Commercial Officer | 14 Feb 2022, 15:06 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 06 Dec 2021 | 0 | $0 | 3 | Chief Commercial Officer | 15 Dec 2021, 15:56 |